about
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future ApplicationsThe long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activityβ-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells.Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors.Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells featuresCharacterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroupAnomalous vascularization in a Wnt medulloblastoma: a case report.Non-canonical Hedgehog/AMPK-Mediated Control of Polyamine Metabolism Supports Neuronal and Medulloblastoma Cell Growth.Breast cancer metastatic to the pituitary gland: a case reportPositron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).High-throughput microRNA profiling of pediatric high-grade gliomas.Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.Chemotherapy and target therapy in the management of adult high- grade gliomas.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation.The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site.MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs.β-Arrestin1/miR-326 Transcription Unit Is Epigenetically Regulated in Neural Stem Cells Where It Controls Stemness and Growth Arrest.IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells.Hedgehog controls neural stem cells through p53-independent regulation of Nanog.microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1.Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs).Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience.Foxm1 controls a pro-stemness microRNA network in neural stem cells.Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor.Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional NetworksTargeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal CancerBRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitorsDNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (CIC) AlterationsInfant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomesKCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience
P50
Q26772309-EF910350-8618-432C-B609-6E0B852E68D3Q33761605-6B41FDBB-A2EC-4D3D-ABC4-E080B8725E1EQ33908911-93E6259D-2C2F-43FE-8530-2FB6E5D5CF01Q34816792-22F2B72E-7EC8-47C7-935B-3BF8715259E0Q34981146-DEC9616C-0016-4F1B-9A5A-2D4AEFB66DE4Q35150189-BED32839-891B-4485-90B2-066E52706A3BQ35710253-41E8897A-1E2B-4CC4-9320-AAAE7B860832Q36077998-BB168938-B9BC-45BE-976E-A24776202D47Q36168155-78FD76DA-DCA1-4CF0-A6CA-1B833A0F74E4Q36235948-48104CB8-6A80-4011-AF59-49675F474450Q37301288-0F481DC6-81E0-415D-B180-7F96A68B7897Q37492187-01B22D69-8614-4A2C-BCB6-824A3CA704B3Q37697396-C574C7E5-E83E-4DCA-8C74-339595F96651Q38029398-F3C31E91-7EB8-41E6-9D7D-098E6E5F258BQ38037048-89D63BD1-E874-4BBC-A179-B9D09DEE8AE7Q38939369-9B23775A-9924-4597-BA4A-E862780D004BQ39004690-51996F33-D434-4D30-BB74-E4C9DF8D6699Q39750898-C10D8A3C-A0C3-4A91-8E18-74B22B3147ABQ41172461-6BFFEAA2-91B3-4697-B7D6-3B93328C10FFQ42127785-2CF5936E-3522-4927-B6B0-0718BFA589ACQ42318314-B6442C61-E00E-43BA-A2FC-3AE7B803C57FQ42324668-F358D156-4090-4EC3-B330-DC57BBFC158AQ42366629-7D6A12DA-744E-41D1-88EE-C6562391DE0BQ42474956-F6C65E76-B07A-4EFE-9205-E4273290A4F7Q42921751-AD6675A3-B61D-446E-8507-26977D96922DQ47144270-7272307B-F858-4643-A3CE-9E1095CF9DBBQ47173747-7ECDE6DE-8CFE-48FA-8F4A-9CF12E55F995Q48283915-E8192AFF-24DA-41C6-8C50-1AD8AC5D5EB6Q51151425-EFAF4B86-6B48-4CBB-81E0-C05DFB36DFDAQ52145667-E7866194-57D6-49F7-9A83-99A3C315E243Q58795103-96D2510B-B5FD-4395-B2DD-5961C0FBB31DQ89696573-0E81AACE-EE04-4D4D-8842-C01EF5F8849BQ89746060-F9E109D7-E750-4A39-9832-ADBE0DDBE051Q90189511-71D5F5D7-90FE-436D-95F5-70532A837A89Q90832636-81280080-9A09-4952-B7EB-428516A4AECAQ91105619-D5D3DBB9-ABE7-45B0-A308-A6A3C709865AQ92077140-BB6D83DF-15A4-46CA-9A66-8050AAB76028
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Evelina Miele
@ast
Evelina Miele
@en
Evelina Miele
@es
Evelina Miele
@sl
type
label
Evelina Miele
@ast
Evelina Miele
@en
Evelina Miele
@es
Evelina Miele
@sl
prefLabel
Evelina Miele
@ast
Evelina Miele
@en
Evelina Miele
@es
Evelina Miele
@sl
P1053
M-4611-2013
P106
P1153
13005324200
P21
P31
P3829
P496
0000-0002-4747-1032